Search

everythinglearnresearchcommunity

for

Search:↓

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Finasteride's effects on prostate cancer are not clear from this text.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Baricitinib successfully treated severe hair loss.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Analog 23 is a promising compound for prostate cancer treatment.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Erlotinib can cause nonscarring hair loss and itchy skin.

EGFR inhibitors can cause yellowish skin eruptions.

Certain genes can predict how well breast cancer patients respond to chemotherapy.